ANTHONY MARTINEZ: Open Payments
NPI 1598712754 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$385,085 in 323 payments from 9 companies in 2025. Trend: 2023 $166,761 · 2024 $278,024 · 2025 $385,085
Speaker / faculty: $293,401Consulting: $40,895Travel & lodging: $32,783Food & beverage: $8,051Speaker / faculty: $5,500Honoraria: $4,455
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 134 | $182,813 |
| ABBVIE INC. | 76 | $90,431 |
| Gilead Sciences, Inc. | 79 | $75,463 |
| Novo Nordisk Inc | 7 | $14,934 |
| Ipsen Biopharmaceuticals, Inc | 8 | $11,249 |
| Cepheid | 2 | $5,500 |
| Braeburn Inc. | 4 | $4,543 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $136 |
| Orexo US, Inc. | 1 | $16 |
Products named: REZDIFFRA, MAVYRET, Epclusa, Wegovy, Descovy, Yeztugo, IQIRVO, GeneXpert.
Industry payments across NY — which companies pay providers there.
